U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 202813

Expand all

QNASL (BECLOMETHASONE DIPROPIONATE)
0.04MG/ACTUATION
Marketing Status: Prescription
Active Ingredient: BECLOMETHASONE DIPROPIONATE
Proprietary Name: QNASL
Dosage Form; Route of Administration: AEROSOL, METERED; NASAL
Strength: 0.04MG/ACTUATION
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N202813
Product Number: 002
Approval Date: Dec 17, 2014
Applicant Holder Full Name: TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
Marketing Status:  Prescription
Patent and Exclusivity Information
QNASL (BECLOMETHASONE DIPROPIONATE)
0.08MG/ACTUATION
Marketing Status: Prescription
Active Ingredient: BECLOMETHASONE DIPROPIONATE
Proprietary Name: QNASL
Dosage Form; Route of Administration: AEROSOL, METERED; NASAL
Strength: 0.08MG/ACTUATION
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N202813
Product Number: 001
Approval Date: Mar 23, 2012
Applicant Holder Full Name: TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top